Table 2.
Effect of telemonitoring and/or telerehabilitation on physical activity and exercise capacity in patients with lung diseases or COVID-19.
| Disease | Study | Exercise capacity | Physical activity | |||||
|---|---|---|---|---|---|---|---|---|
| IG change from pre-intervention | IG effect in comparison with CG | Instrument/tool used to assess the outcome | IG change from baseline | IG effect in comparison with CG | Instrument/tool used to assess the outcome | |||
| Telemonitoring | COPD | Koff, P. 2021 51 | ↑ | ↑ | 6MWT | |||
| Telerehabilitation | COVID-19 | Bermejo-Gil, B. 2021 64 | ↑ | NA | Borg scale | |||
| COPD | Hansen, Henrik 2020 66 | ↑ | = | 6MWT, 30 s sit-to stand test | no | = | Triaxial accelerometer | |
| Stickland, M. 2011 70 | ↑ | = | 12 min walk test | |||||
| Lewis, A. 2021 69 | ↑ | NA | 1 min sit-to stand test | |||||
| Jiménez-Reguera, B. 2020 68 | no | = | 6MWT | |||||
| Telerehabilitation and telemonitoring | COPD | Benzo, R. 2021 71 | NR | = | ActiGraph | |||
| Tsai, L. 2017 81 | ↑ | ↑ | Endurance shuttle walk test | no | = | Triaxial accelerometer | ||
| ↑ | = | 6MWT | ||||||
| Paneroni, M. 2015 78 | ↑ | = | 6MWT | |||||
| Holland, A. 2013 76 | ↑ | NA | 6MWT | |||||
| Marquis, N. 2015 77 | ↑ | NA | 6MWT | |||||
| Galdiz, J. 2020 74 | no | = | 6MWT | |||||
IG: Intervention group; CG: control group; 6MWT: 6-min walking test NA: not applicable. ↑: significantly better outcome; =: no significant difference in outcome change between groups. not reported. NR: data and/or significance level not reported.